Search Results - "Neron, Y."

Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4) by Motzer, R.J., Alyasova, A., Ye, D., Karpenko, A., Li, H., Alekseev, B., Xie, L., Kurteva, G., Kowalyszyn, R., Karyakin, O., Neron, Y., Cosgriff, T., Collins, L., Brechenmacher, T., Lin, C., Morgan, L., Yang, L.

“…RECORD-1 demonstrated clinical benefit of everolimus in patients with metastatic renal cell carcinoma (mRCC) previously treated with sunitinib, sorafenib, or…”
Get full text

2620 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis by Alekseev, B, Yang, L, Alyasova, A, Ye, D, Karpenko, A, Li, H, Xie, L, Kurteva, G, Kowalyszyn, R, Karyakin, O, Neron, Y, Cosgriff, T, Collins, L, Brechenmacher, T, Lin, J, Morgan, L, Motzer, R

Get full text

2634 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis by Yang, L, Alyasova, A, Ye, D, Karpenko, A, Li, H, Alekseev, B, Xie, L, Kurteva, G, Kowalyszyn, R, Karyakin, O, Neron, Y, Cosgriff, T, Collins, L, Brechenmacher, T, Lin, J, Morgan, L, Motzer, R

Get full text

Quality of life in newly diagnosed patients with cervical cancer in Brazil: Results of EVITA study (EVA/LACOG 0215) by Nogueira-Rodrigues, A., de Melo, A.C., Calabrich, A.F.D.C., Cronenberger, E., Torres, K.L., Damian, F., Cossetti, R., De Azevedo, C.R.A.S., da Fonseca, A.J., Nerón, Y., Nunes, J.S., Lopes, A., Thomé, F., Leal, R., Borges, G., Nunes Filho, P.R.S., Zaffaroni Caorsi, F., Freitas, R.D.S., Werutsky, G., Maluf, F.C.

Get full text

Abstract P1-08-27: Advanced stage at diagnosis and worse clinicopathologic features in young woman with breast cancer. A sub-analysis of Brazilian population through the AMAZONA III study (GBECAM 0115) by Franzoi, MA, Rosa, D, Barrios, C, Bines, J, Cronemberger, E, Queiroz, G, Cordeiro de Lima, VC, Junior, R, Couto, J, Emerenciano, K, Resende, H, Crocamo, S, Reinert, T, Van Evyl, B, Neron, Y, Dybal, V, Lazaretti, N, Costamilan, RdC, de Andrade, D, Mathias, C, Zerwes Vacaro, G, Borges, G, Silva, K, Werutsky, G, Morelle, A, Sampaio Filho, CA, Mano, M, Zaffaroni, F, Simon, S, Liedke, PE

“…Abstract BACKGROUND: Breast cancer (BC) in young women is uncommon and often more aggressive. There are disparities in terms of screening coverage, diagnostic…”
Get full text

Abstract P4-12-26: A phase II randomized study of lapatinib in combination with capecitabine, vinorelbine or gemcitabine as first or second line-therapy in patients with HER2 positive metastatic breast cancer progressing after taxane (LACOG 0801) by Gomez, H, Neciosup, S, Tosello, C, Mano, M, Bines, J, Ismael, G, Santi, PX, Pinczowsky, H, Neron, Y, Fanelli, M, Fein, L, Sampaio, C, Lerzo, G, Capo, A, Zarba, JJ, Blajman, C, Varela, MS, Martínez-Mesa, J, Werutsky, G, Barrios, CH

“…Abstract Background: Lapatinib-Capecitabine (LC) is approved for the treatment of advanced or metastatic breast cancer (MBC) whose tumors overexpress HER2 and…”
Get full text

978PQuality of life in newly diagnosed patients with cervical cancer in Brazil: Results of EVITA study (EVA/LACOG 0215) by Nogueira-Rodrigues, A, de Melo, A C, Calabrich, A F D C, Cronenberger, E, Torres, K L, Damian, F, Cossetti, R, De Azevedo, C R A S, da Fonseca, A J, Nerón, Y, Nunes, J S, Lopes, A, Thomé, F, Leal, R, Borges, G, Nunes Filho, P R S, Zaffaroni Caorsi, F, Freitas, R D S, Werutsky, G, Maluf, F C

Get full text

Abstract P1-08-29: Current status of clinical and pathological characteristics of breast cancer patients in Brazil: Results of the AMAZONA III study (GBECAM 0115) by Rosa, D, Barrios, C, Bines, J, Werustky, G, Cronemberger, E, Queiroz, GS, Lima, VC, Freitas-Júnior, R, Couto, J, Emerenciano, K, Resende, H, Crocamo, S, Reinert, T, Van Eyil, B, Néron, Y, Dybal, V, Lazaretti, N, Costamilan, RC, Andrade, DA, Mathias, C, Vacaro, GZ, Borges, G, Torres, KL, Morelle, A, Sampaio Filho, CA, Mano, M, Zaffaroni, F, Simon, S

“…Abstract BACKGROUND Breast cancer (BC) is the most common tumor in women in Brazil with about 60 thousand new cases estimated per year. In low and…”
Get full text

10P Safety and tolerability of first-line (1L) osimertinib (osi) ± platinum-pemetrexed in EGFRm advanced NSCLC: Data from FLAURA2 by Lee, C.K., Planchard, D., Fan, Y., Poltoratskiy, A., Tran, T.V., Leiva Gálvez, M.H., Nishino, K., Yao, W., Biswas, B., Takahashi, T., Nerón, Y., Sriuranpong, V., Koubkova, L., Han, J-Y., Figueroa, A., Ruscanu, C., Taggart, S., Kulkarni, D., Albayaty, M., Escriu, C.

Get full text

A randomized open-label, phase II study of lapatinib/capecitabine, lapatinib/vinorelbine, or lapatinib/gemcitabine in patients (pts) with ErbB2-amplified metastatic breast cancer (MBC) progressing after taxane treatment-GLICO-0801 by Gomez, H. L., Neciosup, S. P., Neron do Nascimento, Y., Ismael, G., Barrios, C. H.

“…Abstract only…”
Get full text

Abstract P1-17-10: Survival outcomes related to health care coverage in breast cancer patients with brain metastases in Brazil: A sub-analysis from the LACOG-0312 study by Albuquerque, C, Debiasi, M, Werutsky, G, Uema, D, Cronenberger, E, Cordeiro de Lima, VC, de Sant'ana, RO, Bines, J, Santi, PX, Goés, RS, Liedke, P, Batista, MLM, Dybal, V, Nerón, YV, Beato, CA, Borges, G, Giacomazzi, J, dos Santos, LV, Ismael, G, Rosa, DD, Azambuja, A, Andrade, D, Martinez-Mesa, J, Zaffaroni, F, Barrios, CH

“…Abstract Background The incidence of brain metastases among women with metastatic breast cancer (MBC) ranges from 10 to 30% depending of breast cancer (BC)…”
Get full text

Abstract P4-10-17: Survival outcomes related to health care coverage in metastatic breast cancer in Brazil: A sub-analysis from the LACOG-0312 study by Werutsky, G, Zaffaroni, F, Uema, D, Cronenberger, E, Cordeiro de Lima, VC, de Sant'ana, RO, Bines, J, Santi, PX, Goés, RS, Liedke, P, Batista, MLM, Dybal, V, Nerón, YV, Beato, CA, Borges, G, Giacomazzi, J, dos Santos, LV, Ismael, G, Rosa, DD, Azambuja, A, Andrade, D, Martinez-Mesa, J, Debiasi, M, Barrios, CH

“…Abstract Background Metastatic breast cancer (MBC) is an incurable disease in which latest therapies have evolving and improving patients survival. Inequities…”
Get full text

Abstract P6-16-04: Real World data and patterns of care of metastatic breast cancer (MBC) in Brazil: First results of LACOG 0312 retrospective study by Barrios, CH, Uema, D, Cronenberger, E, Lima, V, Bines, J, de Sant'ana, RO, Batista, ML, Dybal, V, Liedke, P, Beato, C, Nerón, YV, Giacomazzi, J, dos Santos, L, Ismael, G, Azambuja, A, Andrade, D, Rosa, DD, Borges, G, Mano, M, Martinez-Mesa, J, Zaffaroni, F, Werutsky, G

“…Abstract Background Randomised clinical trials (RCT) are considered a gold standard generating efficacy and safety data supporting drug approval. However, real…”
Get full text